Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Chrystyn

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 12, 2008
Determination of factors controlling the particle size in nanoemulsions using Artificial Neural NetworksAmir Amani, Peter York, Henry Chrystyn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2017
Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhalerMohamad Abadelah, Firisteh Hazim, Henry Chrystyn, et al.
International Journal of Pharmaceutics|March 7, 2006
Co-deposition of salmeterol and fluticasone propionate by a combination inhalerAndrew Theophilus, Alison Moore, Dave Prime, et al.
Respiratory Medicine|November 12, 2013
Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPDHenry Chrystyn, Mark Small, Gary Milligan, et al.
British Journal of Clinical Pharmacology|October 10, 2007
Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbationSyed H R Mazhar, Nahlah E Ismail, Duncan A G Newton, et al.
Pharmaceutical Research|May 19, 2007
Determination of the relative bioavailability of salbutamol to the lungs following inhalation from dry powder inhaler formulations containing drug substance manufactured by supercritical fluids and micronizationCatherine H Richardson, Marcel de Matas, Harold Hosker, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 13, 2014
The inhalation characteristics of patients when they use different dry powder inhalersWahida Azouz, Philip Chetcuti, Harold S R Hosker, et al.
Respiratory Medicine|May 18, 2010
Choosing inhaler devices for people with asthma: current knowledge and outstanding research needsJohn Haughney, David Price, Neil C Barnes, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|February 23, 2010
What happens to patients who have their asthma device switched without their consent?Scott Doyle, Andrew Lloyd, Angela Williams, et al.
BMC Pulmonary Medicine|January 6, 2009
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma controlMike Thomas, David Price, Henry Chrystyn, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 12, 2008
Determination of factors controlling the particle size in nanoemulsions using Artificial Neural NetworksAmir Amani, Peter York, Henry Chrystyn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2017
Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhalerMohamad Abadelah, Firisteh Hazim, Henry Chrystyn, et al.
International Journal of Pharmaceutics|March 7, 2006
Co-deposition of salmeterol and fluticasone propionate by a combination inhalerAndrew Theophilus, Alison Moore, Dave Prime, et al.
Respiratory Medicine|November 12, 2013
Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPDHenry Chrystyn, Mark Small, Gary Milligan, et al.
British Journal of Clinical Pharmacology|October 10, 2007
Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbationSyed H R Mazhar, Nahlah E Ismail, Duncan A G Newton, et al.
Pharmaceutical Research|May 19, 2007
Determination of the relative bioavailability of salbutamol to the lungs following inhalation from dry powder inhaler formulations containing drug substance manufactured by supercritical fluids and micronizationCatherine H Richardson, Marcel de Matas, Harold Hosker, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 13, 2014
The inhalation characteristics of patients when they use different dry powder inhalersWahida Azouz, Philip Chetcuti, Harold S R Hosker, et al.
Respiratory Medicine|May 18, 2010
Choosing inhaler devices for people with asthma: current knowledge and outstanding research needsJohn Haughney, David Price, Neil C Barnes, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|February 23, 2010
What happens to patients who have their asthma device switched without their consent?Scott Doyle, Andrew Lloyd, Angela Williams, et al.
BMC Pulmonary Medicine|January 6, 2009
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma controlMike Thomas, David Price, Henry Chrystyn, et al.
Pageof 9